Contribution of the CmeABC Efflux Pump to Macrolide and Tetracycline Resistance in Campylobacter jejuni
- 1 September 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (9), 3212-3216
- https://doi.org/10.1128/aac.01592-06
Abstract
We investigated the involvement of the CmeABC efflux pump in acquired resistance of Campylobacter jejuni to macrolides and tetracycline. Inactivation of the cmeB gene had no effect on macrolide resistance when all copies of the target gene carried an A2074C mutation. In contrast, the CmeABC pump significantly contributed to macrolide resistance when two or three copies of the 23S rRNA had an A2075G transition. Inactivation of the cmeB gene led to restoration of tetracycline susceptibility in the isolates examined. Complete susceptibility to tetracycline or macrolides, however, was not restored when phenylalanine-arginine β-naphthylamide was used. These data confirm contribution of the CmeABC efflux pump to acquired resistance of Campylobacter jejuni to tetracycline and macrolides.Keywords
This publication has 25 references indexed in Scilit:
- Synergy between Efflux Pump CmeABC and Modifications in Ribosomal Proteins L4 and L22 in Conferring Macrolide Resistance in Campylobacter jejuni and Campylobacter coliAntimicrobial Agents and Chemotherapy, 2006
- Multidrug-resistance efflux pumps ? not just for resistanceNature Reviews Microbiology, 2006
- Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp.Microbes and Infection, 2006
- Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coliJournal of Antimicrobial Chemotherapy, 2005
- Role of Efflux Pumps and Topoisomerase Mutations in Fluoroquinolone Resistance in Campylobacter jejuni and Campylobacter coliAntimicrobial Agents and Chemotherapy, 2005
- Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutationsJournal of Antimicrobial Chemotherapy, 2005
- CmeR Functions as a Transcriptional Repressor for the Multidrug Efflux Pump CmeABC in Campylobacter jejuniAntimicrobial Agents and Chemotherapy, 2005
- In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with gyrA Mutations and the Function of the CmeABC Efflux PumpAntimicrobial Agents and Chemotherapy, 2003
- Experimental Campylobacter jejuni Infection in HumansThe Journal of Infectious Diseases, 1988
- The treatment of campylobacter infections in manJournal of Antimicrobial Chemotherapy, 1987